US.MRNA · Moderna

{
  "risk": {
    "level": "High",
    "reason": "risk management score < 5/10",
    "position": {
      "score": 0.9,
      "details": {
        "atrPct": 8.925574030087095,
        "turnoverUsdM": 352.3638648,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.3
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.MRNA",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 51.877,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 17.9,
      "take_profit_price": 71.7175,
      "target_multiplier": 1.6,
      "technical_strength": 1.43,
      "take_profit_percent": 13.6
    },
    "positionPoints": 0.9,
    "stopLossPoints": 0.6,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 15,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 47,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 47,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 0
  },
  "market": {
    "ma20": 68.5808,
    "ma50": 56.7865,
    "close": 63.15,
    "prevClose": 68.28,
    "avgVolume20": 9870480,
    "volumeRatio": 0.57,
    "changePercent": -7.51
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 0,
    "details": {
      "ret_5d": -0.17515673981191227,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 0,
      "vcp_bonus": 0,
      "vol_ratio": 0.5446879958688073,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.8800774715144583,
      "volat_points": 0,
      "day_range_pct": 0.07315914489311172,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 47,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 54,
        "contribution": 2.7
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 7.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 49.33,
        "contribution": 7.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 4.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 49,
        "contribution": 4.9
      },
      {
        "raw": 16.8,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 56,
        "contribution": 16.8
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 47,
    "details": [
      "基本面分析總分: 2.7/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 7.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 4.9/10分",
      "技術信號分析總分: 16.8/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.7,
      "資金流": 9.2,
      "市場環境": 7.4,
      "情緒分析": 4,
      "技術信號": 16.8,
      "風險管理": 4.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0,
          "epsPoints": 0.75,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 352.3638648,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 3.2,
          "obvPoints": 1.6,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.MRNA",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.67
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 719.70450385,
                "ma50": 718.7308020400001,
                "name": "QQQ",
                "close": 705.94,
                "points": 0.4
              },
              "spy": {
                "ma20": 744.9045070000001,
                "ma50": 743.9900025,
                "name": "SPY",
                "close": 750.71997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 8.925574030087095,
          "atrPoints": 1,
          "cciPoints": 1.6,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140921643,
                "url": "https://finnhub.io/api/news?id=ad1db4b6be88d8cd0e3ddb4d5813892f40565c9119be0162b0369232b28fd01e",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first U.S. participant in its Phase 1 study evaluating mRNA-4200, a tumor-targeted cancer antigen therapy candidate, in patients with advanced or metastatic",
                "category": "company",
                "datetime": 1784185418,
                "headline": "Moderna Doses First US Participant In Its Phase 1 Study Of mRNA-4200, Tumor-Targeted Cancer Antigen Therapy Candidate, For Advanced Or Metastatic Solid Tumors"
              },
              {
                "id": 140892671,
                "url": "https://finnhub.io/api/news?id=f5eb20fba93f312e07c310ee8bf8c0e66eadb4e3e9883c34d31c9724d1fcd058",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (MRNA) reached $66.98 at the closing of the latest trading day, reflecting a -1.89% change compared to its last close.",
                "category": "company",
                "datetime": 1783979406,
                "headline": "Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 140865423,
                "url": "https://finnhub.io/api/news?id=9c8e4ce026832df4e7d0259af159f409a25c41849bb6baff96cdce34fe84e17b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The pullback appears driven by a mix of profit-taking and cautious Wall Street comments after a whopping 48% rally in June and a smaller 3% rally in May.",
                "category": "company",
                "datetime": 1783712233,
                "headline": "MRNA Stock Eyes Worst Week In 11 Months After June Surge — What’s Ahead?"
              },
              {
                "id": 140856731,
                "url": "https://finnhub.io/api/news?id=1ab0b94ca5c3320fabd479de649c38d68888692582fd06f5482b569484475db3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 2.6% in the afternoon session after the European Commission signed a contract to procure up to 24 million doses of the company's vaccine for Respiratory Syncytial Virus (RSV).",
                "category": "company",
                "datetime": 1783638222,
                "headline": "Why Moderna (MRNA) Stock Is Trading Up Today"
              },
              {
                "id": 140856732,
                "url": "https://finnhub.io/api/news?id=e322ebb25f950e49f4530018b3e1fb5036e82c83f93a0cfb93b68a729ff637ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna has delivered a sharp 148.1% gain year to date, yet its low value score and rich market multiples suggest the stock is far from a clear bargain. Year to date, Moderna is up 148.1%, which puts recent enthusiasm firmly ahead of its longer term share price record. Excitement around Moderna's expanded mRNA pipeline beyond vaccines can support growth expectations, while concerns about ongoing losses and the time it may take to turn that pipeline into steady cash flow remain a key risk for...",
                "category": "company",
                "datetime": 1783635130,
                "headline": "Moderna (MRNA) Stock May Sit Above Fair Value Following Pipeline Expansion"
              },
              {
                "id": 140850091,
                "url": "https://finnhub.io/api/news?id=0e44aa21d15e1ff44033083cb3997b69e9cd06bf4d76613889918ec489ead4c1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna, Inc. (NASDAQ:MRNA) is one of the 10 Best Performing American Stocks in June 2026. On July 7, 2026, RBC Capital raised the firm’s price target on Moderna, Inc. (NASDAQ:MRNA) to $45 from $38 and kept a Sector Perform rating on the shares as part of a broader Q2 earnings preview for biotech. RBC said […]",
                "category": "company",
                "datetime": 1783593674,
                "headline": "RBC Capital Raises its Price Target on Moderna (MRNA)"
              },
              {
                "id": 140850088,
                "url": "https://finnhub.io/api/news?id=e847fedf43124783edcb753cd3d81470a44d61c96f4b63d34a1e67601b823d3c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "On July 8, 2026, Moderna, Inc. appointed veteran financial executive Michael McDonnell, former Biogen CFO, to its Board of Directors and Audit Committee, while a federal advisory panel previously backed approval of the company’s first-of-its-kind mRNA influenza vaccine. Together with new programs in autoimmune disease, ovarian cancer and an AI-enabled research platform, these developments highlight Moderna’s push to broaden its mRNA franchise beyond COVID-19 and seasonal respiratory...",
                "category": "company",
                "datetime": 1783591935,
                "headline": "Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?"
              },
              {
                "id": 140825452,
                "url": "https://finnhub.io/api/news?id=a6086c9a0acfe0f026efc4914fc1a26adea1cdffb52524860891fb49682a58a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (MRNA) closed at $81.76 in the latest trading session, marking a +2.51% move from the prior day.",
                "category": "company",
                "datetime": 1783374605,
                "headline": "Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know"
              }
            ],
            "raw_source": [
              {
                "id": 140924528,
                "url": "https://finnhub.io/api/news?id=f1e1715ec5ef89b9077a66a3ae648149c25e397177105374f1afe0fa2ef540fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.",
                "category": "company",
                "datetime": 1784227263,
                "headline": "ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection?"
              },
              {
                "id": 140921837,
                "url": "https://finnhub.io/api/news?id=192e750e79a3e75ab0d468b53d4de78fd222cc21fdcb5c63cb9253fb73f4301d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.",
                "category": "company",
                "datetime": 1784219700,
                "headline": "Exploring the top movers within the S&P500 index during today's session."
              },
              {
                "id": 140918921,
                "url": "https://finnhub.io/api/news?id=a55e4c8b6ce0a21c79c97c228a610dad6931a94cff4a46dfd5fe6ccc4b01ebfb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce patents protecting their innovative lipid nanoparticle (“LNP”) technology against Pfizer and BioNTech Received approximately $178M from Moderna as Arbutus’ share of the noncontingent payment under the March 2026 Settlement Agreement resolving litigation over Moderna’s infringement of Arbutus’ LNP patents Anticipates receipt of a dividend from Genevant in Q3 2026 Expects to return up to approximate",
                "category": "company",
                "datetime": 1784201400,
                "headline": "Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders"
              },
              {
                "id": 140919029,
                "url": "https://finnhub.io/api/news?id=ec7dfff01ad9a972b4e1106cb3ba1b7e1a0767fd8854874d2a6bcf4e0c1e0d8b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first U.S. participant in its Phase 1 study evaluating mRNA-4200, a tumor-targeted cancer antigen therapy candidate, in patients with advanced ...",
                "category": "company",
                "datetime": 1784199600,
                "headline": "Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors"
              },
              {
                "id": 140921643,
                "url": "https://finnhub.io/api/news?id=ad1db4b6be88d8cd0e3ddb4d5813892f40565c9119be0162b0369232b28fd01e",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first U.S. participant in its Phase 1 study evaluating mRNA-4200, a tumor-targeted cancer antigen therapy candidate, in patients with advanced or metastatic",
                "category": "company",
                "datetime": 1784185418,
                "headline": "Moderna Doses First US Participant In Its Phase 1 Study Of mRNA-4200, Tumor-Targeted Cancer Antigen Therapy Candidate, For Advanced Or Metastatic Solid Tumors"
              },
              {
                "id": 140900040,
                "url": "https://finnhub.io/api/news?id=76e7485fea8bbc7883846148f4118bada996ba5602ddc83871a64492383b4f0e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna Inc (NASDAQ:MRNA, XETRA:0QF) is expected to report second quarter results on July 31, with investors focused on the impact of seasonal COVID-19 vaccine demand and updates on the company’s late-stage pipeline, including anticipated Phase III melanoma data. Jefferies analysts expect a...",
                "category": "company",
                "datetime": 1784050500,
                "headline": "Moderna set for uneventful Q2 report ahead of key data readouts, says Jefferies"
              },
              {
                "id": 140893920,
                "url": "https://finnhub.io/api/news?id=47d6d4e74ed1db540632834dce38790a050e1f5ba2d4668c97c2e1fc020011b7",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2256895141/image_2256895141.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MRNA",
                "summary": "Markets remained mixed last week, with sector leadership continuing to rotate beneath a relatively stable broader market.",
                "category": "company",
                "datetime": 1783989300,
                "headline": "ValuEngine Weekly Market Summary And Commentary"
              },
              {
                "id": 140892671,
                "url": "https://finnhub.io/api/news?id=f5eb20fba93f312e07c310ee8bf8c0e66eadb4e3e9883c34d31c9724d1fcd058",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (MRNA) reached $66.98 at the closing of the latest trading day, reflecting a -1.89% change compared to its last close.",
                "category": "company",
                "datetime": 1783979406,
                "headline": "Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note"
              },
              {
                "id": 140885957,
                "url": "https://finnhub.io/api/news?id=c3654f647a3a47105890017a1058d688704c7d5e8383e61c6ed4d24e55ec464f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The company's pipeline is more advanced than ever, but its history shows a pattern of deep, prolonged drops when the market turns.",
                "category": "company",
                "datetime": 1783948328,
                "headline": "What It Means To Hold Moderna Stock In A Crash"
              },
              {
                "id": 140886045,
                "url": "https://finnhub.io/api/news?id=cbed7f50e76169885f3ee752a5d4dc459a65e615e71f72c26bb80ca6f09f9856",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Two of the companies are taking a second-go at FDA approval this summer, while another hopes to cement its leader-status in the battle to bring a new sleep treatment to market.",
                "category": "company",
                "datetime": 1783930800,
                "headline": "Moderna, Takeda and Capricor on the verge of notching big drug approvals"
              },
              {
                "id": 140884386,
                "url": "https://finnhub.io/api/news?id=af5eb902aca1992ec5be596a883f3a2dc814c0cdaac87d634e05625c0cd64bc8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The Morning Bull - US Market Morning Update Monday, Jul, 13 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.4%, as investors digest a mix of cooling inflation and uneven growth signals abroad. Softer price data in countries like France, where inflation sits at 1.8%, suggests global cost of living pressures are easing, which can take some pressure off central banks to keep lifting interest rates. At the same time, weaker industrial output in...",
                "category": "company",
                "datetime": 1783930232,
                "headline": "US Stock Market Today: S&P 500 Futures Rise As Inflation Cools And Earnings Loom"
              },
              {
                "id": 140866318,
                "url": "https://finnhub.io/api/news?id=de5a1bf97e4c73b4b8c964715ac59f0c6f06e02de4899d9fa077f93762668cfd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Stock Market Today: The Dow Jones index rises Friday while SK Hynix spikes in its U.S. debut. Chili's stock breaks out.",
                "category": "company",
                "datetime": 1783716242,
                "headline": "Stock Market Today: Dow Ends Higher; SK Hynix Jumps In U.S. Trading Debut; Moderna Tumbles"
              },
              {
                "id": 140866170,
                "url": "https://finnhub.io/api/news?id=a3aa35610973c4e09e72a60550a3a4d1ed78491ac6d94840e7900b3c81fd6d98",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "(Updates with index/price moves and company/geopolitical news from the first paragraph.) US equit",
                "category": "company",
                "datetime": 1783716056,
                "headline": "Update: US Equity Indexes Rise as Diplomatic Engagements Between Washington, Iran Send Crude Oil Lower"
              },
              {
                "id": 140866172,
                "url": "https://finnhub.io/api/news?id=ad3d65785a11d0ff5301054e3e738273149c937f92547a09f1891e72fe313cdf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "(Updates with market moves at the end of the day and weekly index changes.) US equities rose Frid",
                "category": "company",
                "datetime": 1783715129,
                "headline": "Update: US Equities Rise, Oil Prices Ease as Trump Confirms Iran Talks"
              },
              {
                "id": 140865423,
                "url": "https://finnhub.io/api/news?id=9c8e4ce026832df4e7d0259af159f409a25c41849bb6baff96cdce34fe84e17b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The pullback appears driven by a mix of profit-taking and cautious Wall Street comments after a whopping 48% rally in June and a smaller 3% rally in May.",
                "category": "company",
                "datetime": 1783712233,
                "headline": "MRNA Stock Eyes Worst Week In 11 Months After June Surge — What’s Ahead?"
              },
              {
                "id": 140865010,
                "url": "https://finnhub.io/api/news?id=4c3d354a7751b7e3c25635309edaa7acf06881ecc4f247a89a15c996d87b178e",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1783710301,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 140864232,
                "url": "https://finnhub.io/api/news?id=91a02918a5278124662a610b3899e8198d2c7971f595e01efcfbf99480df0d7a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna, ImmunityBio, and Sarepta are all cratering today despite bullish recent news and no negative catalysts in sight, leaving investors scrambling to understand whether the biotech sector's monster 2026 run has finally hit a wall.",
                "category": "company",
                "datetime": 1783699478,
                "headline": "Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech Rout"
              },
              {
                "id": 140863212,
                "url": "https://finnhub.io/api/news?id=37a712ddbbcb97c1e777b6e97d5101753ca739fd59fb9c22b266a1e2d9fdd0a1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The Iran war and a tug-of-war between AI stocks and other parts of the market have left the S&P 500 stuck in a range.  On Friday, the S&P 500’s healthcare sector was the only major sector trading down more than 0.1%: It was down 0.7%.  Moderna was the S&P’s biggest laggard, while UnitedHealth was the big drag on the Dow.",
                "category": "company",
                "datetime": 1783698237,
                "headline": "Only 1 Major S&P 500 Sector Is Really Struggling Today"
              },
              {
                "id": 140862289,
                "url": "https://finnhub.io/api/news?id=c8728c954ec0457bbc0355faa6edee84f50fc80691ec4a97c3b60539cf9855e5",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Wondering which stocks are making significant price gaps? Explore the S&P500 index on Friday to find the gap up and gap down stocks in today's session.",
                "category": "company",
                "datetime": 1783694100,
                "headline": "Which S&P500 stocks are gapping on Friday?"
              },
              {
                "id": 140860978,
                "url": "https://finnhub.io/api/news?id=f52c8250e0b7c5bf63adede8719b8b36ec36adf202be2253cbdc14a0b6cdcb3a",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Get insights into the top gainers and losers in the S&P500 index of Friday's pre-market session.",
                "category": "company",
                "datetime": 1783686900,
                "headline": "These S&P500 stocks that are showing activity before the opening bell on Friday."
              },
              {
                "id": 140862541,
                "url": "https://finnhub.io/api/news?id=45fdd898ddb635e3ea7e62217e7471f63db3b33b03ca233604a1fcde9a798b28",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/10/New-York-City--New-York---September-18-2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Intel stock has more than doubled this year, but JPMorgan has named the chipmaker one of its highest-conviction short ideas for Q3.",
                "category": "company",
                "datetime": 1783677879,
                "headline": "Intel Stock Has Doubled, So Why Is JPMorgan Calling It a Top Short?"
              },
              {
                "id": 140856731,
                "url": "https://finnhub.io/api/news?id=1ab0b94ca5c3320fabd479de649c38d68888692582fd06f5482b569484475db3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 2.6% in the afternoon session after the European Commission signed a contract to procure up to 24 million doses of the company's vaccine for Respiratory Syncytial Virus (RSV).",
                "category": "company",
                "datetime": 1783638222,
                "headline": "Why Moderna (MRNA) Stock Is Trading Up Today"
              },
              {
                "id": 140856732,
                "url": "https://finnhub.io/api/news?id=e322ebb25f950e49f4530018b3e1fb5036e82c83f93a0cfb93b68a729ff637ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna has delivered a sharp 148.1% gain year to date, yet its low value score and rich market multiples suggest the stock is far from a clear bargain. Year to date, Moderna is up 148.1%, which puts recent enthusiasm firmly ahead of its longer term share price record. Excitement around Moderna's expanded mRNA pipeline beyond vaccines can support growth expectations, while concerns about ongoing losses and the time it may take to turn that pipeline into steady cash flow remain a key risk for...",
                "category": "company",
                "datetime": 1783635130,
                "headline": "Moderna (MRNA) Stock May Sit Above Fair Value Following Pipeline Expansion"
              },
              {
                "id": 140853823,
                "url": "https://finnhub.io/api/news?id=2a26c769e2fe723713c3ca7993c43989e9007a56a38e092914496d144fde5a7e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues.",
                "category": "company",
                "datetime": 1783617083,
                "headline": "Moderna secures up to 24 million RSV vaccine dose contract with Europe"
              },
              {
                "id": 140850090,
                "url": "https://finnhub.io/api/news?id=90c98a48106d0d071d0d6539d0652f35fc081f2126ae01931236734102528e61",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second quarter 2026 financial results, and provide ...",
                "category": "company",
                "datetime": 1783594800,
                "headline": "Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026"
              },
              {
                "id": 140850091,
                "url": "https://finnhub.io/api/news?id=0e44aa21d15e1ff44033083cb3997b69e9cd06bf4d76613889918ec489ead4c1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna, Inc. (NASDAQ:MRNA) is one of the 10 Best Performing American Stocks in June 2026. On July 7, 2026, RBC Capital raised the firm’s price target on Moderna, Inc. (NASDAQ:MRNA) to $45 from $38 and kept a Sector Perform rating on the shares as part of a broader Q2 earnings preview for biotech. RBC said […]",
                "category": "company",
                "datetime": 1783593674,
                "headline": "RBC Capital Raises its Price Target on Moderna (MRNA)"
              },
              {
                "id": 140850088,
                "url": "https://finnhub.io/api/news?id=e847fedf43124783edcb753cd3d81470a44d61c96f4b63d34a1e67601b823d3c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "On July 8, 2026, Moderna, Inc. appointed veteran financial executive Michael McDonnell, former Biogen CFO, to its Board of Directors and Audit Committee, while a federal advisory panel previously backed approval of the company’s first-of-its-kind mRNA influenza vaccine. Together with new programs in autoimmune disease, ovarian cancer and an AI-enabled research platform, these developments highlight Moderna’s push to broaden its mRNA franchise beyond COVID-19 and seasonal respiratory...",
                "category": "company",
                "datetime": 1783591935,
                "headline": "Will New Board Appointment And mRNA Flu Progress Change Moderna's (MRNA) Pipeline Diversification Narrative?"
              },
              {
                "id": 140845441,
                "url": "https://finnhub.io/api/news?id=da22802b2eda457620ba1411857f52798b7b1503ccfea26b9b639dc0951b3b84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "(Updates with market moves at the end of the day and latest developments.) The Dow Jones Industri",
                "category": "company",
                "datetime": 1783543202,
                "headline": "Update: Dow Logs Worst Day in 4 Weeks Amid Renewed US-Iran Tensions"
              },
              {
                "id": 140845445,
                "url": "https://finnhub.io/api/news?id=110e7076a4558bc37104c2602ca57cd4a882a6febdf966c780b80acb8657bc04",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "US equity indexes closed mixed Wednesday after President Donald Trump warned of more strikes on Iran",
                "category": "company",
                "datetime": 1783542469,
                "headline": "US Equity Markets Mixed After Trump Warns of Additional Strikes on Iran"
              },
              {
                "id": 140845542,
                "url": "https://finnhub.io/api/news?id=349042fdb58e62a9028c6292e347b5b33b9c9c4da04883b7fc3172ba702dd965",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna  stock has been on a long-term downtrend since the pandemic, and following a sharp run-up in June that saw shares gain nearly 50%, momentum appears to be fading.  Moderna  fell 6.4% to $74.63 on Wednesday.  Shares have slid since then, losing nearly 9% over the past two sessions.",
                "category": "company",
                "datetime": 1783540680,
                "headline": "Why Moderna Stock Is the S&P 500’s Big Loser Today"
              },
              {
                "id": 140843288,
                "url": "https://finnhub.io/api/news?id=d5ede8f585f623422b4ab059ee2e3c57d07bb05828754e457259c4d5a7652e1c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "(Updates with latest market prices and developments.) US stocks were lower intraday after Preside",
                "category": "company",
                "datetime": 1783532386,
                "headline": "Update: Wall Street Falls Intraday as Trump Threatens to Hit Iran Again"
              },
              {
                "id": 140844537,
                "url": "https://finnhub.io/api/news?id=370518d0128fb5ab455f216fe2fdea1725e9d6bcca61fd414972dd6761174b47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The iShares USA Momentum Factor ETF is up 0.3%, while the while the Invesco Momentum ETF was moving in and out of positive territory.  Momentum ETFs like the iShares fund have actually added energy stocks, which were rising in the wake of the latest wave of re-escalation in the Iran war.  Chip stocks, many of which were actually up on the day, are also major players in momentum ETFs.",
                "category": "company",
                "datetime": 1783532165,
                "headline": "Momentum ETFs Are Actually Holding Up"
              },
              {
                "id": 140843362,
                "url": "https://finnhub.io/api/news?id=597f4902dfd05c08eeacaf56c3d2203bd898010321778f32442a1e1312d5a219",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Major US biopharmaceutical companies' performance in the second half of the year is likely to be dri",
                "category": "company",
                "datetime": 1783529860,
                "headline": "Biopharma Companies' Second-Half Performance to be Largely Driven by Fundamentals, Morgan Stanley Says"
              },
              {
                "id": 140842401,
                "url": "https://finnhub.io/api/news?id=567a839f2eac63296149dfed3ee1a72cffb17192f146fd9e30f68ba39427bd4a",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.",
                "category": "company",
                "datetime": 1783528501,
                "headline": "Explore the top gainers and losers within the S&P500 index in today's session."
              },
              {
                "id": 140841649,
                "url": "https://finnhub.io/api/news?id=46cf1067762772bdaff0bf3cd43eb85b6816d116b9c6119f06b2aaa77d698dba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Biopharma sector's performance in H2 is expected to be driven more by company fundamentals rather th",
                "category": "company",
                "datetime": 1783523510,
                "headline": "Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says"
              },
              {
                "id": 140841131,
                "url": "https://finnhub.io/api/news?id=184ab29f606db1393fafdf742f7523325b403b70a7618e1fc5906c3e35970cdd",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Wednesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.",
                "category": "company",
                "datetime": 1783521301,
                "headline": "Gapping S&P500 stocks in Wednesday's session"
              },
              {
                "id": 140845008,
                "url": "https://finnhub.io/api/news?id=4a277941766a5de0378493dafe626ec2f71fa68672a90db59eec27da35febbda",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders will",
                "category": "company",
                "datetime": 1783517708,
                "headline": "9 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 140842639,
                "url": "https://finnhub.io/api/news?id=e3c8c78faca763456a5113d64219c755674488df3e625f6f0fc935d770bbba1a",
                "image": "https://image.cnbcfm.com/api/v1/image/108313293-1779985301248-gettyimages-2264128506-raa-broadcom260303_npRyT.jpeg?v=1783530430&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "Here are the companies making headlines in midday trading.",
                "category": "company",
                "datetime": 1783516753,
                "headline": "Stocks making the biggest moves midday: Broadcom, Chevron, Alibaba, Carnival & more"
              },
              {
                "id": 140851433,
                "url": "https://finnhub.io/api/news?id=f5da537e857022812576c66b6e6328b00abd252b3d1ab8c76d7ae6a44ea0d1cd",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Morgan Stanley  analyst Matthew Harrison   maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $33 to $39.",
                "category": "company",
                "datetime": 1783516345,
                "headline": "Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $39"
              },
              {
                "id": 140839974,
                "url": "https://finnhub.io/api/news?id=ec8843d6c8224e9622ac1006028d42faed76988dfd28d5a93e7856793c594033",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Stay updated with the S&P500 stocks that are on the move in today's pre-market session.",
                "category": "company",
                "datetime": 1783514100,
                "headline": "Wednesday's pre-market session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 140841616,
                "url": "https://finnhub.io/api/news?id=961c0a32e8a2697dab9deacd629e37f144c77ccb61b2833357916b0c6031e247",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Oil prices spiked following an exchange of strikes between the US and Iran",
                "category": "company",
                "datetime": 1783512720,
                "headline": "Dow Jones and Nasdaq start lower as Trump says Iran ceasefire 'over'"
              },
              {
                "id": 140839747,
                "url": "https://finnhub.io/api/news?id=330deea0f937ba4fc68084a259ccf67f7595ac07a1ae24c96525a42b66911ac5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience CAMBRIDGE, MA / ACCESS Newswire / July 8, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the appointment of Michael McDonnell ...",
                "category": "company",
                "datetime": 1783508400,
                "headline": "Moderna Appoints Michael McDonnell to Board of Directors"
              },
              {
                "id": 140834558,
                "url": "https://finnhub.io/api/news?id=e023a6ea06713ccff1b215e8acf7fc27c2f92ddaca6d23732d3d8f3aae1d9e15",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Arbutus expects to receive around $179 million from Moderna.",
                "category": "company",
                "datetime": 1783448881,
                "headline": "ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week"
              },
              {
                "id": 140831673,
                "url": "https://finnhub.io/api/news?id=c51622ca2d7ba1d3675c92f52af4f8918995e63fce8e26043dfe70b4e1372f2b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (MRNA), TG Therapeutics (TGTX), and Agios Pharmaceuticals (AGIO) will see increased scrutiny",
                "category": "company",
                "datetime": 1783436655,
                "headline": "Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says"
              },
              {
                "id": 140833660,
                "url": "https://finnhub.io/api/news?id=9290cb26cc0b705fab84a44c4bb28771dabbab0bae1ab9b4a9a8e3e64536841a",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "RBC Capital  analyst Luca Issi   maintains Moderna (NASDAQ:MRNA) with a Sector Perform and raises the price target from $38 to $45.",
                "category": "company",
                "datetime": 1783425710,
                "headline": "RBC Capital Maintains Sector Perform on Moderna, Raises Price Target to $45"
              },
              {
                "id": 140833661,
                "url": "https://finnhub.io/api/news?id=fce7340a61e6e29e7cdb43cc4881dd7bafe3e7352264ecf61b28ab2da2807c6d",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "B of A Securities  analyst Dimple Gosai   maintains Moderna (NASDAQ:MRNA) with a Underperform and raises the price target from $34 to $38.",
                "category": "company",
                "datetime": 1783419782,
                "headline": "B of A Securities Maintains Underperform on Moderna, Raises Price Target to $38"
              },
              {
                "id": 140828378,
                "url": "https://finnhub.io/api/news?id=320439d729b277339bfeaca883c1773627fd9b3d69936522b4364850bfeb8119",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna's growth story is just beginning.",
                "category": "company",
                "datetime": 1783416900,
                "headline": "Moderna Stock Is Soaring. Is It Too Late to Buy?"
              },
              {
                "id": 140825452,
                "url": "https://finnhub.io/api/news?id=a6086c9a0acfe0f026efc4914fc1a26adea1cdffb52524860891fb49682a58a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (MRNA) closed at $81.76 in the latest trading session, marking a +2.51% move from the prior day.",
                "category": "company",
                "datetime": 1783374605,
                "headline": "Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know"
              },
              {
                "id": 140821679,
                "url": "https://finnhub.io/api/news?id=e417f0bbb48196563d43efb3e0c4a5727402b839a8324a731be011c44b54bd6a",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Stay informed about the performance of the S&P500 index in the middle of the day on Monday. Uncover the top gainers and losers in today's session for valuable insights.",
                "category": "company",
                "datetime": 1783355701,
                "headline": "Stay informed with the top movers within the S&P500 index on Monday."
              },
              {
                "id": 140819547,
                "url": "https://finnhub.io/api/news?id=8f36db0f39d5c343f533b4cc188c6e182516ef6d9434d6760b4824a02baf7672",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.",
                "category": "company",
                "datetime": 1783341301,
                "headline": "Monday's pre-market session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 140818670,
                "url": "https://finnhub.io/api/news?id=5bb378871c4d7250110c755b530ad54ad40bcf2da5fe3ace6f349cc9076ef393",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_48_b0208efde3.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Thursday's jobs report came in far below forecasts, initially easing pressure on the Federal Reserve, before a fresh slide in memory and semiconductor stocks dragged the Nasdaq lower even as the Dow closed at a record. Tesla sold off despite its best delivery quarter in years, healthcare names caught a bid, and SK Hynix lined up what would be the largest US listing ever by a foreign company.",
                "category": "company",
                "datetime": 1783331949,
                "headline": "Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway."
              },
              {
                "id": 140818450,
                "url": "https://finnhub.io/api/news?id=8516c4a7959120da8d8950894403ed1a7173625d5052a5c7833b13be37ffa78f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The Morning Bull - US Market Morning Update Monday, Jul, 6 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 futures up about 0.4% and E-mini Nasdaq-100 futures up around 1.2%, as investors weigh cooling market anxiety against a packed data week. Volatility gauges like VIX futures are down roughly 2%, which means investors are currently pricing in a calmer trading day. At the same time, the ISM Services PMI, existing home sales, and the Federal Reserve meeting...",
                "category": "company",
                "datetime": 1783325367,
                "headline": "US Stock Market Today: S&P 500 Futures Rise As Inflation Jitters Temporarily Ease"
              },
              {
                "id": 140807809,
                "url": "https://finnhub.io/api/news?id=7210549475fc6a0d7463ca6e3d657226af06eac09f2959a9b729342bfd346624",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna, Inc. (NASDAQ:MRNA) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer highlighted the stock’s significant gains during the year, as he said: If you look at the market’s best performers year to date, nearly all of them are either companies that […]",
                "category": "company",
                "datetime": 1783175414,
                "headline": "Jim Cramer Says “For the First Time in Ages, I Like Having a Position in Moderna”"
              },
              {
                "id": 140807702,
                "url": "https://finnhub.io/api/news?id=840cf4c4b248a268fb56ef7d1b5a446690efab5b6af1a96de06409dd422450bf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The stock market trades largely sideways and oil dips to pre-Iran war prices heading into the final week before Q2 earnings. Here's what to watch.",
                "category": "company",
                "datetime": 1783173887,
                "headline": "Stock Market Week Ahead: Oil Hints At A Paradigm Shift"
              },
              {
                "id": 140812645,
                "url": "https://finnhub.io/api/news?id=d406aced064f84d135af82cd08c77df47c6e66da5a89e0d7894f6ab5dd22a3a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "MarketBeat's weekly roundup covers a weaker June jobs report, tech sector rotation, and top analyst picks including TSLA, AVGO, PLTR, MRNA, and NEE heading into Q2 earnings season.",
                "category": "company",
                "datetime": 1783162800,
                "headline": "MarketBeat Week in Review – 06/29 - 07/03"
              },
              {
                "id": 140801030,
                "url": "https://finnhub.io/api/news?id=d4da7690014aec5ca3d6621051a6b421f5efe051d0949a3619f68c2596f13244",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "When a stock and the analysts covering it disagree this sharply, one of them is about to be wrong.",
                "category": "company",
                "datetime": 1783099620,
                "headline": "Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives?"
              },
              {
                "id": 140801324,
                "url": "https://finnhub.io/api/news?id=a9f7a9e0b40d2f656a855f2e74f975952bde653e4cea66f35587704bf5bb4f8a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "For most of the past three years, Jim Cramer kept his distance from Moderna, treating the biotech stock with skepticism bordering on avoidance. The Cambridge, Massachusetts, company had become synonymous with the pandemic trade, and Cramer’s enthusiasm faded as demand for Covid-era vaccines dried ...",
                "category": "company",
                "datetime": 1783094580,
                "headline": "Jim Cramer turns bullish on health care stock after years of doubt"
              },
              {
                "id": 140800044,
                "url": "https://finnhub.io/api/news?id=6a64d2682b456ce39b982ce5c7ed3f119bd9b7219dd3dc983948bba84dd903d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.",
                "category": "company",
                "datetime": 1783092855,
                "headline": "Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?"
              },
              {
                "id": 140801112,
                "url": "https://finnhub.io/api/news?id=5d0fcbac5cc5b764db3a7a66357d599a00971ea60c0776def7e158542f3aa154",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna surges 33.5% after the company outlines plans to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and cell therapies.",
                "category": "company",
                "datetime": 1783092720,
                "headline": "MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week?"
              },
              {
                "id": 140802433,
                "url": "https://finnhub.io/api/news?id=62723bd3c7a9defce0d3ae2513b6b9539026160175ddd370ab9c4da81406ba8d",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1783085724,
                "headline": "8 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 140798416,
                "url": "https://finnhub.io/api/news?id=56d9d1dd698470fd040e168cb69dc952403f7a8bd1bc1e3ef3e7d1adef0f852e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.",
                "category": "company",
                "datetime": 1783072926,
                "headline": "3 Cash-Heavy Stocks with Warning Signs"
              },
              {
                "id": 140798363,
                "url": "https://finnhub.io/api/news?id=f2b915b1f074e5f37f7616a7064372b7119a260bf73d37cf940a4f558c3954db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The Morning Bull - US Market Morning Update Friday, Jul, 3 2026 US stock futures are slightly weaker this morning, with S&P 500 contracts edging down around 0.01%, as investors weigh softer US data against rising borrowing costs. The US private sector added 98,000 jobs in June, fewer than in May and below forecasts, which hints that hiring is cooling but unemployment near 4.3% still points to plenty of people in work. At the same time, the ISM Manufacturing PMI sits at 53.3, so factories are...",
                "category": "company",
                "datetime": 1783066507,
                "headline": "US Stock Market Today: S&P 500 Futures Slip On Cooling Jobs And Rate Jitters"
              },
              {
                "id": 140793730,
                "url": "https://finnhub.io/api/news?id=afc6f972edca8e59c70f0dd58bf9394983a07e6f89b0020f28d80fa3ace38c75",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Thursday.",
                "category": "company",
                "datetime": 1783019100,
                "headline": "Thursday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 140792023,
                "url": "https://finnhub.io/api/news?id=1b2cfcadbb8d51bc8a515709b049fcc4c163eaecd6b9d58fce0cdcc7a1a170b7",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1783010101,
                "headline": "These S&P500 stocks are moving in today's session"
              },
              {
                "id": 140792941,
                "url": "https://finnhub.io/api/news?id=e573ed15d365fa27ecc51d79658582f21c9e6fd32b7581b3896cb4c010a66615",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "FEATURE  Stocks traded mixed Thursday following a jobs report that showed the U.S. labor market grew at a slower pace in June.  Strategy advanced 6.3% as higher cryptocurrencies prices boosted the largest corporate holder of Bitcoin Robinhood Markets rose 4.",
                "category": "company",
                "datetime": 1783009020,
                "headline": "Tesla, Rivian, Strategy, Moderna, Sandisk, Blue Owl, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140791149,
                "url": "https://finnhub.io/api/news?id=f09c8c1698e312770965c7fd176ba6bff3c2ec9b9b64abbd72a6c7b76eea81ab",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/02/Close-Up-Of-Rivian-Outdoor-Sign.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery forecast. Other companies such as Nexa Resources SA (NEXA) and Moderna Inc (MRNA) also saw gains in today&#39;s session.",
                "category": "company",
                "datetime": 1782987887,
                "headline": "Rivian Automotive, Tenax Therapeutics, Robinhood And Other Big Stocks Moving Higher On Thursday"
              },
              {
                "id": 140791120,
                "url": "https://finnhub.io/api/news?id=233b7ac50abe0742971f1567c47077b52c4ff2476e0bf977d51d0666f74aff41",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "https://t.co/sFqLF8qeSI",
                "category": "company",
                "datetime": 1782983924,
                "headline": "WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be Over"
              },
              {
                "id": 140787657,
                "url": "https://finnhub.io/api/news?id=ce17c9b20616cb8ef7fb4c956cf8e01b2a5840726dcd42cb21f3b2815fa23a4d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Shares of Palo Alto Networks, American Airlines Group, and Moderna climbed amid a series of positive catalysts for the companies.",
                "category": "company",
                "datetime": 1782965899,
                "headline": "Why Did PANW, AAL, MRNA Surge To 52-Week Highs?"
              },
              {
                "id": 140792449,
                "url": "https://finnhub.io/api/news?id=61b321aff28d9e37c54b5110047f1cec1b326ca8b0f5ed7545a9e24fa3530c17",
                "image": "https://image.cnbcfm.com/api/v1/image/108329655-4ED3-MM-D-BLOCK-070126.jpg?v=1782947477&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "CNBC's Jim Cramer talks about his take on Moderna's stock performance and business outlook.",
                "category": "company",
                "datetime": 1782934819,
                "headline": "Moderna's now got a lot going for it, says Jim Cramer"
              },
              {
                "id": 140792769,
                "url": "https://finnhub.io/api/news?id=430370236514a6a4b1271b2adaccacf8a22ed2b4d79e1244d44379c922d5fc09",
                "image": "https://image.cnbcfm.com/api/v1/image/108329657-4ED3-MM-D-BLOCK-SHORT-070126.jpg?v=1782947563&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "CNBC's Jim Cramer talks about his take on Moderna's stock performance and business outlook.",
                "category": "company",
                "datetime": 1782934593,
                "headline": "I'm excited about Moderna's turn but it's had a huge run: Jim Cramer"
              },
              {
                "id": 140792257,
                "url": "https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2",
                "image": "https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.",
                "category": "company",
                "datetime": 1782933515,
                "headline": "Meta's new cloud business will be instantly profitable, says Jim Cramer"
              },
              {
                "id": 140792450,
                "url": "https://finnhub.io/api/news?id=b96976863ba687c527e49a3f43a3026e48124bf4d995f19dca177bd6671423b2",
                "image": "https://image.cnbcfm.com/api/v1/image/108000894-1771434677666-108000894-1719932078582-gettyimages-2151784856-MODERNA_RSV_VACCINE.jpg?v=1771437699&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "CNBC's Jim Cramer said Moderna's expanding pipeline in treatments for cancer and other diseases provides a compelling long-term investment thesis.",
                "category": "company",
                "datetime": 1782931819,
                "headline": "Jim Cramer says this former Covid market darling is finally investable again"
              },
              {
                "id": 140778764,
                "url": "https://finnhub.io/api/news?id=a5f382c66932d2b4871504c07f479d39cf47e49a81a0d239e1c7c56d53ab9e18",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Seven S&P 500 stocks have already tripled in 2026, with memory giant Sandisk far in front All are AI stocks.",
                "category": "company",
                "datetime": 1782903608,
                "headline": "Sandisk Leads Seven S&P 500 Stocks That Have Skyrocketed In 2026"
              },
              {
                "id": 140789859,
                "url": "https://finnhub.io/api/news?id=54f7ab2cfc7b74c1dfc24d9501cc20a104ccb030004054cea054bd25e735033a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines faces a multi-year path to revenue.",
                "category": "company",
                "datetime": 1782903600,
                "headline": "Short Squeeze Alert—Moderna Stock Surges on New Strategy"
              },
              {
                "id": 140779466,
                "url": "https://finnhub.io/api/news?id=ecd3f80dab9713af69a81351cf0be22f79963a87edb26217ed26a54873eca4a0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The list is dominated by semiconductor and computer-hardware manufacturers.",
                "category": "company",
                "datetime": 1782853980,
                "headline": "The 20 best-performing stocks in the S&P 500 for the first half of 2026"
              },
              {
                "id": 140774429,
                "url": "https://finnhub.io/api/news?id=067baa4fbbda9e662c4b4eac4aae39e307c57bf4c3755332a8fe8b6e9f807ecd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna's flu vaccine may not fuel a further recovery for the hard-hit COVID-19-affected stock.",
                "category": "company",
                "datetime": 1782844500,
                "headline": "Is Moderna Stock a No-Brainer Buy After a Key FDA Win?"
              },
              {
                "id": 140772314,
                "url": "https://finnhub.io/api/news?id=e10497ea38e4fbad71eb7072d597a29bb43582fc3c78ed5ce80d21a5cf7c2964",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2194222148/image_2194222148.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MRNA",
                "summary": "Vertex Pharmaceuticals Incorporated offers predictable CF cash flows and pipeline catalysts in pain, hematology & renal (Pove for IgAN). Click for this VRTX update.",
                "category": "company",
                "datetime": 1782810196,
                "headline": "Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech"
              },
              {
                "id": 140767819,
                "url": "https://finnhub.io/api/news?id=6ae4a91c85afc969147cfd0c9704faf264d1019d1be95001971d48f3b80a9b75",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Comcast created a stir among communication services stocks with a plan to spin off its media and entertainment assets into a new publicly traded company.",
                "category": "company",
                "datetime": 1782763975,
                "headline": "Stocks Rally to Start a Big Holiday Week: Stock Market Today"
              },
              {
                "id": 140781757,
                "url": "https://finnhub.io/api/news?id=5baed29654721b5d98fe3ce501ae03081ebb89e584dc62b245c3de70b534c11e",
                "image": "https://image.cnbcfm.com/api/v1/image/108262197-1770323920909-gettyimages-2260105869-bb1_2632_uxvikxrq.jpeg?v=1782775477&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "The Dow rose more than 300 points on Monday to post its first close above 52,000. Alphabet, a new addition to the 30-stock index, jumped almost 5%.",
                "category": "company",
                "datetime": 1782760725,
                "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session"
              },
              {
                "id": 140765446,
                "url": "https://finnhub.io/api/news?id=d9ce9227f83812c8375c292a2411e4b04a0dca1e07fcfea1c6517855e3ae1b31",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna hit a 52-week high after it unveiled a strategy to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and AI-driven R&D.",
                "category": "company",
                "datetime": 1782752520,
                "headline": "MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines"
              },
              {
                "id": 140765973,
                "url": "https://finnhub.io/api/news?id=36d72bab19bf2969b94365c82ebfb05c4de7d45b8b98e17dc12dc474b602f8e2",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/29/Short-Selling-Stock-Market-2-Scheme-Scam.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Betting against Palantir, Rocket Lab and Strategy was June&#39;s smartest move — leveraged short funds soared up to 130%, crushing every single stock in the S&amp;P 500.",
                "category": "company",
                "datetime": 1782747519,
                "headline": "Big Shorts In Palantir, Rocket Lab, MSTR Crush S&P 500 In June's Hottest Trades"
              },
              {
                "id": 140766928,
                "url": "https://finnhub.io/api/news?id=548d721cf8c243734658f5b924db2acd7a1472652cb3b12136cfc23b5b1084e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in MRNA shares.",
                "category": "company",
                "datetime": 1782747010,
                "headline": "MRNA Stock Spikes as Moderna Shares mRNA Pipeline Update"
              },
              {
                "id": 140766482,
                "url": "https://finnhub.io/api/news?id=e8268aabe90b2f1030e795a9b392052e3c1ae570501afff308d8b2868372149d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/29/Moderna.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "A classic &#39;flag&#39; pattern has formed on the chart of Moderna (MRNA). This continuation pattern suggests the rally will continue.",
                "category": "company",
                "datetime": 1782727401,
                "headline": "Stock Of The Day: Will The Moderna Rally Continue?"
              },
              {
                "id": 140760509,
                "url": "https://finnhub.io/api/news?id=337ac098885636449238758e63c48f4fad5c91798a779231f37aa746dc0a730c",
                "image": "https://www.chartmill.com/images/uploads/THUMBNAILS_CHARTMILL_1000_528_39_9880df21cf.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "The week closed with the Strait of Hormuz still bleeding headlines and crude already down nine percent. Sunday, Washington and Tehran said they were standing down and heading to Doha. Whether that holds is anyone's guess, but for one trading day, at least, the market gets to price the calmer outcome.",
                "category": "company",
                "datetime": 1782726305,
                "headline": "Hormuz Goes Quiet, Software Wakes Up, and Burry Picks a Side"
              },
              {
                "id": 140760346,
                "url": "https://finnhub.io/api/news?id=87d0483d402fe018062d849f158d268e60829cd8708130b34471bae13d892028",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The Morning Bull - US Market Morning Update Monday, Jun, 29 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.3% and Nasdaq-100 futures weaker by roughly 1.2%, as investors weigh solid US spending against stubborn inflation. Core PCE inflation sits at 3.4% year over year, which means the cost of living is still rising faster than the Federal Reserve would like, while real personal spending grew 0.3% and incomes rose 0.7% in May. This suggests...",
                "category": "company",
                "datetime": 1782720507,
                "headline": "US Stock Market Today: S&P 500 Futures Slip As Sticky Inflation Keeps Fed Cautious"
              },
              {
                "id": 140760366,
                "url": "https://finnhub.io/api/news?id=e86473ba50e8124b3df0e3e88725ffdc5e5e638e4d34c6f4407e21f321ff0bd7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna stock is up 125.51% in 2026, driven by an FDA flu vaccine win, a corporate pivot, and an expanding pipeline.",
                "category": "company",
                "datetime": 1782717923,
                "headline": "This COVID Stock Market Winner Is Making a Comeback, Up 125% Year to Date"
              },
              {
                "id": 140759254,
                "url": "https://finnhub.io/api/news?id=e4b671943c3aa5483e540ad3217ee775a8f2d10baeb08ee38e475a48eb3dc124",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.",
                "category": "company",
                "datetime": 1782712506,
                "headline": "MRNA Stock Rallies Over 40% In June: Moderna Bets Its Future On Cancer, Autoimmune Disease And AI-Powered mRNA"
              },
              {
                "id": 140758639,
                "url": "https://finnhub.io/api/news?id=fd4fbf93207cd1d8ae71c2b5f5882d7d232ad53329a161849d9b3f8ff9a56021",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business outlook.",
                "category": "company",
                "datetime": 1782705415,
                "headline": "Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?"
              },
              {
                "id": 140741718,
                "url": "https://finnhub.io/api/news?id=fa7c14f456755ff30fd6aeba587affd482bd114e232f27ef1bbbe8dadc8f3dae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "STORY: U.S. stocks ended marginally lower on Friday, with the Dow and S&P 500 each shedding less than a tenth of a percent, and the Nasdaq losing about a quarter of a percent.AI-related chip stocks suffered steep declines as some investors worry that the massive spending to build AI data centers may take too long to pay off.Robert Conzo is CEO and managing director of The Wealth Alliance.\"The AI ship, although we love the technology, everyone loves the idea, it's like a cruise ship where the captain knows where they're going, the passengers don't know where this is going, passengers get nervous. The captain is the CEOs of these companies, putting billions and billions and billions of dollars of infrastructure into the AI. The market is the passengers saying, 'When are we going to be profitable here? At what point does profitability come to play?' Analysts are saying 2030, could be longer. And when prices go up, up, up, up higher, suddenly you start to question that value.\"A report that OpenAI was considering delaying its public debut until next year also weighed on risk sentiment related to AI stocks.:: AppleElsewhere in the market, shares of Apple rallied more than 3% and partly rebounded from a selloff a day earlier. The tech giant on Thursday raised iPad and MacBook prices, blaming soaring memory and storage chip costs.:: ArchiveShares of ON Semiconductor tumbled almost 24% after the company agreed to acquire chip maker Synaptics in an all-stock deal valued at about $7 billion. Shares of Synaptics dipped more than 3.5%.:: ModernaOn the flipside, shares of Moderna surged almost 13% to their highest level since 2024 after the drug developer hosted an investor event and showcased its pipeline.",
                "category": "company",
                "datetime": 1782511545,
                "headline": "S&P 500 ends lower; chips tumble and Moderna rallies"
              },
              {
                "id": 140740654,
                "url": "https://finnhub.io/api/news?id=4e2d0ee8436f8e9647ae855bac9c8669b4c29d9467ab2fc90f978b131ae08999",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "US equity indexes were lower on Friday amid a sell-off in technology stocks and despite a decline in",
                "category": "company",
                "datetime": 1782505162,
                "headline": "US Equity Markets End Lower Amid Technology Stocks Sell-Off"
              },
              {
                "id": 140741486,
                "url": "https://finnhub.io/api/news?id=0362db4386220b3de95609887fc21d115c726907ea553454a7a60d603be56a80",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Stocks took an early hit on news that ChatGPT parent OpenAI might push its public offering to 2027, and a midday recovery faded into the close.",
                "category": "company",
                "datetime": 1782504691,
                "headline": "Stocks Struggle After OpenAI IPO Blow: Stock Market Today"
              },
              {
                "id": 140739367,
                "url": "https://finnhub.io/api/news?id=c11200c20562c6161f926365974938c1a971ccc3353c699441e89c0e09626f66",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Yahoo Finance's Jared Blikre takes a closer look at some of Friday's trending tickers and stories, including Moderna (MRNA), Netflix (NFLX), and ON Semiconductor (ON).",
                "category": "company",
                "datetime": 1782503690,
                "headline": "Trending: Netflix stock bounces back, Moderna surges post–investor day, ON Semi plummets"
              },
              {
                "id": 140738838,
                "url": "https://finnhub.io/api/news?id=e91c2b0f4ac08ab15ff4b8aa3a67fdbce3e4806d88c2ece3ecebfbb37b44459a",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.",
                "category": "company",
                "datetime": 1782500701,
                "headline": "Discover which S&P500 stocks are making waves on Friday."
              },
              {
                "id": 140737991,
                "url": "https://finnhub.io/api/news?id=4f1f92e9bfd556033ca1e9a7a947069be8194bd99d29c4f03bd80a254adeb6e9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Lilly, AbbVie and J&J extend winning streaks.",
                "category": "company",
                "datetime": 1782496164,
                "headline": "Lilly, J&J and AbbVie Hit New Highs"
              },
              {
                "id": 140746666,
                "url": "https://finnhub.io/api/news?id=c19899df934fdeb1fd874f9a41fd4d047a58cb90598f23bb5949d722329421a5",
                "image": "https://image.cnbcfm.com/api/v1/image/108327728-6ED4-REQ-062626-MarketsNOW.jpg?v=1782507676&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "CNBC Markets Now provides a look at the day's market moves with commentary and analysis from Michael Santoli, CNBC Senior Markets Commentator.",
                "category": "company",
                "datetime": 1782493607,
                "headline": "CNBC Markets Now: June 26, 2026"
              },
              {
                "id": 140746667,
                "url": "https://finnhub.io/api/news?id=3bc3083f9462bffd7db62bb3524ddff5e5bc51dea1bd5c4e2933adc3583cdfbd",
                "image": "https://image.cnbcfm.com/api/v1/image/108327732-6ED4-REQ-062626-MarketClose.jpg?v=1782507765&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "CNBC brings you fast, accurate, and actionable business news and market updates.",
                "category": "company",
                "datetime": 1782493549,
                "headline": "Post Market Wrap: June 26, 2026"
              },
              {
                "id": 140737076,
                "url": "https://finnhub.io/api/news?id=c1a676c37531c97d9038d97178e0db4705207ed0c4764295496954ccbc7639d4",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Friday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1782491701,
                "headline": "Friday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 140738210,
                "url": "https://finnhub.io/api/news?id=53395b1219f471e4595d56218d23b2899a95298b5faca5c46fdc2d295feeb9f2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.",
                "category": "company",
                "datetime": 1782491065,
                "headline": "3 Mid-Cap Stocks Walking a Fine Line"
              },
              {
                "id": 140737975,
                "url": "https://finnhub.io/api/news?id=093aa118cb2ad79fd96ec2971794ddc98a863a844a9ea0656861e49b8af7c81c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Investors continued to rotate out of artificial-intelligence momentum names and into lagging sectors.  Flash memory product supplier  Sandisk  fell 7.8% and is set to close lower on the week after rising 22% on Thursday.  Nvidia  moved 0.8% lower to $194.12.",
                "category": "company",
                "datetime": 1782490920,
                "headline": "Moderna, Nvidia, Sandisk, Palantir, ON Semi, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140738042,
                "url": "https://finnhub.io/api/news?id=f8b316ddbf026bf067b5337eb62e61e0db952dee0b18064b45a8553ecf61881b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Shares of Moderna (NASDAQ:MRNA) are up 14% to $68 and change in afternoon trading Friday, extending a remarkable run for the mRNA pioneer. Intraday, MRNA stock hit a new 52-week high of $69.29. The rally easily outpaces peer vaccine makers. Merck (NYSE:MRK) stock is up 2% to $128, while Pfizer (NYSE:PFE) stock trades up 2% ... Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?",
                "category": "company",
                "datetime": 1782489673,
                "headline": "Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer?"
              },
              {
                "id": 140736678,
                "url": "https://finnhub.io/api/news?id=3038664d97ac7d1daf0c10601b93304de255e6d67a4da96d5a72fbffbd13b631",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna shares pace toward their highest close since late 2024 after unveiling a new cell therapy program.",
                "category": "company",
                "datetime": 1782488160,
                "headline": "Why Moderna Stock Is Soaring and Leading the S&P 500 Today"
              },
              {
                "id": 140738508,
                "url": "https://finnhub.io/api/news?id=b6c8e793bb24acd1bea60922327fe149603f2d15ce0e1051f5d9882dc4f33c72",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/26/Capricor-Therapeutics.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its Duchenne muscular dystrophy therapy.",
                "category": "company",
                "datetime": 1782482800,
                "headline": "What's Going On With Capricor Therapeutics Stock On Friday?"
              },
              {
                "id": 140738484,
                "url": "https://finnhub.io/api/news?id=ef5060389f60276f62729917f5f1870ad05f242bbb0eaf9b66b4ccc315ed7ca7",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "https://www.cdc.gov/ebola/situation-summary/index.html",
                "category": "company",
                "datetime": 1782479453,
                "headline": "CDC Raises Its Response Level To Congo Ebola Outbreak To Level 1 Activation, Its Highest Level; Says Risk Of Ebola Spreading In The U.S. Remains Low"
              },
              {
                "id": 140737291,
                "url": "https://finnhub.io/api/news?id=f967565bde51a202a27c29a0137a0c215d2512f7031b456cec9015d4e7b99a56",
                "image": "https://image.cnbcfm.com/api/v1/image/108222303-1762434766877-gettyimages-2235744008-CANADA_BIOMANUFACTURING.jpeg?v=1782492668&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "Here are the companies making headlines in midday trading.",
                "category": "company",
                "datetime": 1782478763,
                "headline": "Stocks making the biggest moves midday: Moderna, ON Semiconductor, Rocket Lab, Eli Lilly, Sandisk & more"
              },
              {
                "id": 140739766,
                "url": "https://finnhub.io/api/news?id=7c07ab38bc8d9ecae236ed2e57cea6535a0fa42b06a95094b87937da4d155169",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Piper Sandler  analyst Edward Tenthoff   maintains Moderna (NASDAQ:MRNA) with a Overweight and raises the price target from $69 to $77.",
                "category": "company",
                "datetime": 1782478083,
                "headline": "Piper Sandler Maintains Overweight on Moderna, Raises Price Target to $77"
              },
              {
                "id": 140737119,
                "url": "https://finnhub.io/api/news?id=56f9e46e1432152fa65c931fe9cde8e8b6df6fab68663c198a15d7480f5b37f5",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/26/Walmart-Misses-Nasdaq-100--LULU-Slumps.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Semiconductors cratered Friday, dragging the stock market lower, while health care and software led a rotation and oil sank below $69",
                "category": "company",
                "datetime": 1782476528,
                "headline": "Chip Rout Drags Nasdaq 100, Oil Sinks Below $69: Stock Market Today"
              },
              {
                "id": 140737755,
                "url": "https://finnhub.io/api/news?id=f23f759c9fd728a1b1fb3759156918f510975303e85ddc2d718d44a3c015aec3",
                "image": "https://image.cnbcfm.com/api/v1/image/108327486-6ED1-REQ-062626-NewsLM.jpg?v=1782487552&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "CNBC brings you fast, accurate, and actionable business news and market updates.",
                "category": "company",
                "datetime": 1782473784,
                "headline": "The Late Morning Rundown: June 26, 2026"
              },
              {
                "id": 140736206,
                "url": "https://finnhub.io/api/news?id=cdc9a33779d720a37b959998e39d27a423105e6862becd0d2ae9974a8fbfd7f2",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/26/Display-Of-Stock-Market-Quotes.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected first-quarter financial results. Other big gainers in today&#39;s session include FuelCell Energy Inc (NASDAQ: FCEL) up 17.6%, BitVentures Limited (NASDAQ: BVC) up 14.1%, and ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) up 10.3% after receiving a positive recommendation for a market authorization in Europe. ",
                "category": "company",
                "datetime": 1782469136,
                "headline": "Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday"
              },
              {
                "id": 140732820,
                "url": "https://finnhub.io/api/news?id=17903f2bee44892f21784a0646ffc3b5c0e976512b169f8eb34b96ab6092b970",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "It's not just a \"pandemic stock,\" after all.",
                "category": "company",
                "datetime": 1782451200,
                "headline": "This Stock Has Already Doubled This Year and Is Still Racing Towards a Major Catalyst"
              },
              {
                "id": 140733375,
                "url": "https://finnhub.io/api/news?id=d68fa1e82d9193414834040ef2a4e7ab618d023394755a21872a9a917116e85d",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MRNA",
                "summary": "2026-06-26. The following slide deck was published by Moderna, Inc.",
                "category": "company",
                "datetime": 1782443545,
                "headline": "Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science"
              },
              {
                "id": 140733345,
                "url": "https://finnhub.io/api/news?id=29266ce48b5aeb818ef8e44f37e530d55214a14fee98c02045f95625116be240",
                "image": "",
                "source": "SeekingAlpha",
                "related": "MRNA",
                "summary": "",
                "category": "company",
                "datetime": 1782443339,
                "headline": "MRNY: The Yield Is Too Aggressive For Long-Term Sustainability"
              },
              {
                "id": 140731107,
                "url": "https://finnhub.io/api/news?id=291783959732d39cffbe7b97a7a408d9ac0b4b1a467eaa06f3e351e4ce38a35b",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "MRNA",
                "summary": "Moderna, Inc. (MRNA) Discusses Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science June 25, 2026 9:00 AM EDTCompany...",
                "category": "company",
                "datetime": 1782423131,
                "headline": "Moderna, Inc. (MRNA) Discusses Advancements in mRNA Technology, Clinical Modalities, and Future Horizons in Science Transcript"
              },
              {
                "id": 140723991,
                "url": "https://finnhub.io/api/news?id=eef6f2009ca9056861d7c824be07a0b44a8c6a27f22da75f54b87646b7de1eda",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Provides broad overview of Company's research and early development programs expected to continue to fuel future growth Highlights validation of T-cell engager modality with mRNA-2808 in multiple myeloma, supporting rapid advancement of second T-cell ...",
                "category": "company",
                "datetime": 1782385200,
                "headline": "Moderna Science Day Highlights Expanding Potential of mRNA Platform"
              },
              {
                "id": 140731740,
                "url": "https://finnhub.io/api/news?id=e09bfd442960d63cca3c2fcf7cf713be5f65d111cd16651fa309fb52ed6629c8",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Provides broad overview of Company&#39;s research and early development programs expected to continue to fuel future growthHighlights validation of T-cell engager modality with mRNA-2808 in multiple myeloma, supporting",
                "category": "company",
                "datetime": 1782371558,
                "headline": "Moderna Outlines Research And Early Development Programs Fueling Future Growth; Highlights T‑Cell Engager Modality And Unveils In Vivo CAR‑T Entry"
              },
              {
                "id": 140720027,
                "url": "https://finnhub.io/api/news?id=095eb3bf06656cecf28e5a2b161f84ef071b2a2f1fdae4de02b7d157e0f324ed",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The FDA’s Vaccines and Related Biological Products Advisory Committee has unanimously backed Moderna’s mRNA-based flu shot, mFlusiva, for adults 50 and older, after phase 3 data showed it to be about 27% more effective than a standard flu vaccine. This endorsement positions Moderna’s mRNA platform for a potential second major commercial use beyond COVID-19, expanding its role in routine respiratory vaccination for older adults. We’ll now explore how this unanimous FDA panel support for...",
                "category": "company",
                "datetime": 1782342936,
                "headline": "How Unanimous FDA Panel Support For mRNA Flu Shot At Moderna (MRNA) Has Changed Its Investment Story"
              },
              {
                "id": 140711291,
                "url": "https://finnhub.io/api/news?id=f16bcf3069d3f71c6085a38299bb5545f00b5d817e17d56e1d54bbbce33a555c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2224254980/image_2224254980.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MRNA",
                "summary": "Moderna received a unanimous advisory committee vote supporting mRNA-1010, its flu vaccine, for adults 50 and older. Read more on MRNA stock here.",
                "category": "company",
                "datetime": 1782275320,
                "headline": "Moderna: Flu Vaccine Progress Is Only Part Of The Story"
              },
              {
                "id": 140708428,
                "url": "https://finnhub.io/api/news?id=5c732a378f5924a066b64318bfa188e562a9805a0a77b859e0737e44f5bf46ec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Flagship Pioneering, the scientific innovation company behind Moderna, Generate Biomedicines, and more than 100 other life sciences ventures, and Lean Business Services Company, a Public Investment Fund company and the Kingdom's national leader in digital health transformation, today announced a strategic collaboration to advance healthcare innovation and AI-enabled biomedical research in Saudi Arabia.",
                "category": "company",
                "datetime": 1782254700,
                "headline": "Flagship Pioneering and Lean Business Services Company Announce Collaboration to Advance Healthcare Innovation and AI-Enabled Biomedical Research in Saudi Arabia"
              },
              {
                "id": 140708429,
                "url": "https://finnhub.io/api/news?id=9fcd5c64801782f10ed3fd59b6d41500e837007388eff1c71240e57c647fd6c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (MRNA) closed at $61 in the latest trading session, marking a +2.79% move from the prior day.",
                "category": "company",
                "datetime": 1782251405,
                "headline": "Moderna (MRNA) Rises As Market Takes a Dip: Key Facts"
              },
              {
                "id": 140705126,
                "url": "https://finnhub.io/api/news?id=069346933a9fc61e47fc082d338400f3b9fdc916af1d622c08044cd645169a6b",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.",
                "category": "company",
                "datetime": 1782241500,
                "headline": "Which S&P500 stocks are moving on Tuesday?"
              },
              {
                "id": 140701816,
                "url": "https://finnhub.io/api/news?id=83194a81f1bf06c29625ac3301c189dc186f3aa0c269e33936a365610b43e658",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/164210757/image_164210757.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MRNA",
                "summary": "Moderna, Inc. analysis: VWAP resistance, R&D wins, Q1 revenue surge, and mRNA-1010 risks missed flu contracts—the rating shifts to Sell. Click for an update.",
                "category": "company",
                "datetime": 1782210358,
                "headline": "Moderna: From Buy To Sell After 128.2% Surge (Rating Downgrade)"
              },
              {
                "id": 140700953,
                "url": "https://finnhub.io/api/news?id=d9e536315b97c3074e2a19053e6928ca3cc7f6cc86cc2c744f0b11afce046908",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1928832415/image_1928832415.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "MRNA",
                "summary": "Moderna, Inc. shifts beyond Covid with mRNA vaccines like mFlusiva, combo shots, and oncology catalysts. Click for more on MRNA stock prospects.",
                "category": "company",
                "datetime": 1782202884,
                "headline": "Moderna: The Comeback Is Now In Full Swing"
              },
              {
                "id": 140697313,
                "url": "https://finnhub.io/api/news?id=0f3eff295b98e87f319702e937ccfce673428e1e99189701de6d8886e9003821",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna just received fantastic news.",
                "category": "company",
                "datetime": 1782167400,
                "headline": "Should You Buy Moderna Before Aug. 5?"
              },
              {
                "id": 140696128,
                "url": "https://finnhub.io/api/news?id=78e25a6682e5d9c15befa1ea809674d5a0c01514528fef3f3b387c666609dae1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "A selloff of large technology stocks sent the Nasdaq reeling, but the Dow managed to weather the storm. The Dow rose 163 points, or 0.3%. The Nasdaq fell 1.3%. The S&P 500 fell 0.4%, even though breadth was solid for much of the afternoon.",
                "category": "company",
                "datetime": 1782158491,
                "headline": "Nasdaq Drops 1.3%, Dow Weathers the Mag 7 Storm"
              },
              {
                "id": 140694636,
                "url": "https://finnhub.io/api/news?id=ebc9b2b902d4d057f0b7586981632024e503d45a65eef814196e69484a8477d2",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Monday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1782155101,
                "headline": "Monday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 140694076,
                "url": "https://finnhub.io/api/news?id=6ecb686af7a4b7c8cdcb1fcd58beb827e80bd777fa39b92f73cd0904f4657704",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Shares of the vaccine maker have been on a hot streak, most recently catalyzed by a positive update from the FDA.",
                "category": "company",
                "datetime": 1782150360,
                "headline": "Moderna Stock’s 6-Day Rally Ends in a Dive. Why It’s One of the S&P 500’s Biggest Losers Today."
              },
              {
                "id": 140696173,
                "url": "https://finnhub.io/api/news?id=3392778fa8384dc7470ee5706a1baa3cf55b04a5d558cd9995811e02674d6c91",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "One feature within the Barchart Stock Screener tool that resonated with me is a pre-built filter known as the J-Pattern or J-Curve.",
                "category": "company",
                "datetime": 1782142215,
                "headline": "Intel Stock and 3 Other Winners I Found Using Barchart’s High-Octane Stock Screener"
              },
              {
                "id": 140692064,
                "url": "https://finnhub.io/api/news?id=d87acd74c04d614915e0556acd6295b5a279a4101d5029f9b927e866ae241dbc",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Looking for the S&P500 stocks that are experiencing notable gaps on Monday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1782138900,
                "headline": "Which S&P500 stocks are gapping on Monday?"
              },
              {
                "id": 140690910,
                "url": "https://finnhub.io/api/news?id=c57289a0dde4dc116d2266def0fd4dc8282fe687836fa204d9bd0f95cd1ad23b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The panel unanimously said that the benefits of Moderna's mRNA jab outweigh its risks in preventing influenza in certain age groups.",
                "category": "company",
                "datetime": 1782128605,
                "headline": "Moderna’s mRNA flu vaccine passes FDA AdCom, review underway"
              },
              {
                "id": 140677391,
                "url": "https://finnhub.io/api/news?id=4f84c42557322a8f87860065e738d5e1bce66be09c080c35016a151c219699db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The company's pending vaccine approvals could help the stock continue its rise.",
                "category": "company",
                "datetime": 1781956200,
                "headline": "Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?"
              },
              {
                "id": 140670133,
                "url": "https://finnhub.io/api/news?id=1446c476154c7c49ae7318506a1ffce313e752309c975edbd8b2c81c61317a90",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna stock gains 3.5% after FDA advisory panel votes 9-0 that mFlusiva's benefits outweigh risks in influenza prevention in older adults, ahead of an Aug. 5 decision.",
                "category": "company",
                "datetime": 1781870640,
                "headline": "MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing"
              },
              {
                "id": 140673129,
                "url": "https://finnhub.io/api/news?id=075140e4bea0cb7f593206d14cb39e41b48ff52982094c976e70472b7d26582d",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/19/Kyiv--Ukraine---December-01--2020-Modern.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Moderna’s experimental flu vaccine won unanimous FDA panel backing ahead of an Aug. 5 decision.",
                "category": "company",
                "datetime": 1781856383,
                "headline": "Moderna's Flu Vaccine Clears Key FDA Panel Vote As Advisory Committee Backs Shot 9-0"
              },
              {
                "id": 140666709,
                "url": "https://finnhub.io/api/news?id=c97214baa02e1f2b2c9d3eef69dabe9acc78679bb7474002637f52dd9352823b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Jefferies noted that FDA decisions aligned with advisory committee recommendations 84% of the time between 2020 and 2025.",
                "category": "company",
                "datetime": 1781819104,
                "headline": "MRNA Stock Clocks Best Week In Over 4 Years On FDA Advisory Committee Endorsement For Flu Vaccine"
              },
              {
                "id": 140665243,
                "url": "https://finnhub.io/api/news?id=193ba4d73aac2e17ba8fadbae63676d01d8410a6b576d406165e8d15addff92c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "FDA Prescription Drug User Fee Act (PDUFA) goal date remains August 5, 2026 CAMBRIDGE, MA / ACCESS Newswire / June 18, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological ...",
                "category": "company",
                "datetime": 1781812800,
                "headline": "Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine"
              },
              {
                "id": 140665088,
                "url": "https://finnhub.io/api/news?id=fc9fa47f8b80804aaf63671d74b98a7ec4df21d08305b68376d454e68a7c93be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Stock Market Today; The Dow Jones index rises Thursday following reports of a signed U.S.-Iran peace deal. Moderna breaks out past a buy point.",
                "category": "company",
                "datetime": 1781812044,
                "headline": "Stock Market Today: Nasdaq, Russell Pace Rebound; SpaceX Off As This Firm Breaks Out (Live Coverage)"
              },
              {
                "id": 140663983,
                "url": "https://finnhub.io/api/news?id=94bcfb18241fabfc0a1b2c10b4e90498be938af0c6e0f82b68a2a4f471aba412",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Stock Market Today; The Dow Jones index rises Thursday following reports of a signed U.S.-Iran peace deal. Moderna breaks out past a buy point.",
                "category": "company",
                "datetime": 1781802280,
                "headline": "Stock Market Today: Nasdaq Climbs On Iran Peace Deal; Moderna Breaks Out; JPMorgan Reverses (Live Coverage)"
              },
              {
                "id": 140664211,
                "url": "https://finnhub.io/api/news?id=18e2d73c50e46d164fc814772109d2f9cd50b33d6c29d34e7efcef59a7c52ca0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (MRNA) has been struggling to shake one label for years: Covid winner. That label helped to make the company famous, but it also became a problem for the stock when pandemic demand dropped and investors questioned whether Moderna could develop a stable business beyond one historic product ...",
                "category": "company",
                "datetime": 1781801365,
                "headline": "Moderna just got a signal investors can’t ignore"
              },
              {
                "id": 140666470,
                "url": "https://finnhub.io/api/news?id=6d0a812969d3c0437c43de665211cb62bd611eed92a717cf0df14ac52b721ae5",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "FDA Prescription Drug User Fee Act (PDUFA) goal date remains August 5, 2026CAMBRIDGE, MA / ACCESS Newswire / June 18, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration&#39;s (FDA)",
                "category": "company",
                "datetime": 1781798478,
                "headline": "Moderna Says FDA Advisory Committee Unanimously Backs mRNA-1010 Seasonal Flu Vaccine For Adults 50–64 and 65+, Voting 9-0 That Benefits Outweigh Risks Ahead Of August 5 PDUFA Decision Date"
              },
              {
                "id": 140663087,
                "url": "https://finnhub.io/api/news?id=fc25a2a4b98a1fbc4e312f471cadf6736b64ca14de665a2ff323fcec2a535a5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Stock Market Today; The Dow Jones index rises Thursday following reports of a signed U.S.-Iran peace deal. Moderna breaks out past a buy point.",
                "category": "company",
                "datetime": 1781797123,
                "headline": "Stock Market Today: Dow Pops On Iran Peace Deal; Moderna Breaks Out, AI Stocks Jam (Live Coverage)"
              },
              {
                "id": 140666471,
                "url": "https://finnhub.io/api/news?id=86bb0e91d2efc7173dc4be3011506fa7558faba8a7c1d2a6d6e09646a7e15c26",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/18/Two-Vials-Of-The-Moderna-Vaccine-With-A-.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.",
                "category": "company",
                "datetime": 1781794820,
                "headline": "Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF"
              },
              {
                "id": 140666472,
                "url": "https://finnhub.io/api/news?id=37524d3f917e1226cd0d122cbe3858d376f674cc89eda1ba9e4476c1c48b243e",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-advisers-vote-favor-modernas-flu-vaccine-2026-06-18/",
                "category": "company",
                "datetime": 1781794513,
                "headline": "'US FDA advisers vote in favor of Moderna's flu vaccine' - Reuters"
              },
              {
                "id": 140663287,
                "url": "https://finnhub.io/api/news?id=457e275d9f0582ceba029d930b5ef14cc12684c38a0ad2328da35d9edb7d981a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (NASDAQ:MRNA) shares moved higher on Thursday, building on the previous session’s strong gains as investors focused on a key review of the company’s influenza vaccine by a U. S.",
                "category": "company",
                "datetime": 1781790927,
                "headline": "Moderna Extends Rally as FDA Advisory Panel Reviews Flu Vaccine Application (MRNA)"
              },
              {
                "id": 140661736,
                "url": "https://finnhub.io/api/news?id=2732b79c5214090f6076106ec782d82f0a3727a870245af054b727f849c0bdc4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The Morning Bull - US Market Morning Update Thursday, Jun, 18 2026 US stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.1%, as investors weigh stubborn trade price pressures against a steady Federal Reserve. Import prices for May rose 1.9%, with fuel and lubricants jumping 12.5%, which means businesses are facing higher costs on what they buy from overseas. Export prices climbed 1.3%, the sixth straight monthly rise, hinting that US goods sold...",
                "category": "company",
                "datetime": 1781770718,
                "headline": "US Stock Market Today: S&P 500 Futures Edge Higher As Trade Price Pressures Build"
              },
              {
                "id": 140660446,
                "url": "https://finnhub.io/api/news?id=9e49d3e5607947b90a5cc0242dcb4289fb8a1e841d47988aeaa7379f7a1e9947",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "They haven't peaked yet.",
                "category": "company",
                "datetime": 1781761800,
                "headline": "These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead"
              },
              {
                "id": 140659179,
                "url": "https://finnhub.io/api/news?id=63966d5c03f0bbd92181bf08b440413e4e4909d95bcff25c9b93a6b74684e3f8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna Inc. (NASDAQ:MRNA) is one of the 10 Stocks Making Investors Richer. Moderna extended its winning streak to a fifth consecutive day on Wednesday, climbing 11.55 percent to end at $61.80 apiece, as investors loaded their portfolios ahead of its Investor Day. In a notice, Moderna Inc. (NASDAQ:MRNA) said that it will host an Investor […]",
                "category": "company",
                "datetime": 1781740674,
                "headline": "Moderna (MRNA) Soars 11% Ahead of Investor Day"
              },
              {
                "id": 140659180,
                "url": "https://finnhub.io/api/news?id=80089bdb78ab57e018dc4827460c05d9b0541e0971d6265ccad8cd3e2b4bb9f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "(Updates with index/price moves, FedWatch outlook, macro data, and political/company news from the f",
                "category": "company",
                "datetime": 1781730248,
                "headline": "Update: US Equity Indexes Drop as Bets for Higher Interest Rates Jump After Fed Eliminates Easing Bias"
              },
              {
                "id": 140657354,
                "url": "https://finnhub.io/api/news?id=0ec2743a40ee289db4cb588aaeb5be0fabfaac86811eb664e628d12c3d158145",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "US equity indexes were lower on Wednesday as government bond yields rose and the Federal Reserve ann",
                "category": "company",
                "datetime": 1781727956,
                "headline": "US Equity Markets End Lower After Government Bond Yields Rise, Fed's Policy Statement"
              },
              {
                "id": 140659182,
                "url": "https://finnhub.io/api/news?id=4cb74ab8aac0692da80965823787e0fb5770c36dccf84ed3bc472d454810a00c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Biotech stocks climbed Wednesday after the Food and Drug Administration signaled the end of a \"nail-biting journey\" for UniQure.",
                "category": "company",
                "datetime": 1781727346,
                "headline": "Biotech Stocks Surge As UniQure 'Nail-Biting Journey' Comes To An End"
              },
              {
                "id": 140671470,
                "url": "https://finnhub.io/api/news?id=63cfbb8bf1c7767bf665747bd71f118903532887a7fb67ee87bb13fc69d4e084",
                "image": "https://image.cnbcfm.com/api/v1/image/108318127-1780926637460-gettyimages-2279843810-TFSPI_07062026-5783.jpeg?v=1780926674&w=1920&h=1080",
                "source": "CNBC",
                "related": "MRNA",
                "summary": "Stocks fell on Wednesday after the Federal Reserve's so-called \"dot plot\" suggested that an interest rate hike could be in the cards for 2026.",
                "category": "company",
                "datetime": 1781726205,
                "headline": "Thursday's big stock stories: What’s likely to move the market in the next trading session"
              },
              {
                "id": 140656332,
                "url": "https://finnhub.io/api/news?id=c493445324e00d302e431b6ef982e96c09cd01ca1ad912a5708b07c35349082c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index falling 1.3% and",
                "category": "company",
                "datetime": 1781725081,
                "headline": "Sector Update: Healthcare Stocks Retreat Late Afternoon"
              },
              {
                "id": 140655826,
                "url": "https://finnhub.io/api/news?id=265cb75ab509eba4dfab8db74ccbb0f2e920489416ee32a923628006f267de8c",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Stay updated with the movements of the S&P500 index one hour before the close of the markets on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1781723100,
                "headline": "Stay informed with the top movers within the S&P500 index on Wednesday."
              },
              {
                "id": 140654032,
                "url": "https://finnhub.io/api/news?id=85610cac41c22f2b1c82ccb9817096d022723e30a07f2644cdf55f2f4e25d645",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "MRNA",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Wednesday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1781714100,
                "headline": "Uncover the latest developments among S&P500 stocks in today's session."
              },
              {
                "id": 140655113,
                "url": "https://finnhub.io/api/news?id=c4c5f7c4f6f98452f559315b36897c2a0c93f5fe8d1796c82621696c3915737d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna jumps after FDA briefing documents on mFlusiva appear more constructive than expected ahead of a key advisory panel review.",
                "category": "company",
                "datetime": 1781709060,
                "headline": "MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns"
              },
              {
                "id": 140652808,
                "url": "https://finnhub.io/api/news?id=08708e74206cd80f911849bb4b505758428fd606f5db4e2e637ae57bf0576416",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the 12 Best Growth Stocks Trading in Oversold Territory. On May 20, Roivant Sciences reported its financial results for FQ4 and the full year FY2026, alongside a comprehensive business update. The company finished the year with $4.3 billion in consolidated cash and marketable securities, providing a runway into […]",
                "category": "company",
                "datetime": 1781703966,
                "headline": "Here is Why Roivant (ROIV) is One of the Best Growth Stocks Trading in Oversold Territory"
              },
              {
                "id": 140653707,
                "url": "https://finnhub.io/api/news?id=4ae5a9bbcd85a05e76a428715b589add886b6461ea4a2023c61ddea7fb2f6fff",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (MRNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.",
                "category": "company",
                "datetime": 1781701860,
                "headline": "Moderna (MRNA) Surges 6.3%: Is This an Indication of Further Gains?"
              },
              {
                "id": 140651924,
                "url": "https://finnhub.io/api/news?id=337a57bfdec57e51b7d53b397fa0abe9618ed5e2500f7021402915de9e15d6cf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 25, 2026. The event will feature an overview of Moderna's research and ...",
                "category": "company",
                "datetime": 1781694000,
                "headline": "Moderna to Host Investor Event - Science Day"
              },
              {
                "id": 140654818,
                "url": "https://finnhub.io/api/news?id=8f7128ddb107fe1511e30860a1b427e981483cc6a07e7a71bb08083e1042dea4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "June Nasdaq 100 E-Mini futures (NQM26) are up +0.54% this morning, signaling a rebound from yesterday’s selloff, while investors await the first Federal Reserve rate decision under Kevin Warsh.",
                "category": "company",
                "datetime": 1781692641,
                "headline": "Nasdaq Futures Climb as Chip Stocks Rebound Ahead of First Fed Decision Under Warsh"
              },
              {
                "id": 140655968,
                "url": "https://finnhub.io/api/news?id=8c49dc14057fb833058c8d27b7c384e3af529fcb3aee690a546ebb1ac240e6c0",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/17/Two-Vials-Of-The-Moderna-Vaccine-With-A-.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Moderna flu vaccine faces a key FDA advisory panel review as analysts weigh approval odds, postmarketing study costs, and growth potential.",
                "category": "company",
                "datetime": 1781684632,
                "headline": "FDA Panel Set To Debate Moderna Flu Shot"
              },
              {
                "id": 140649874,
                "url": "https://finnhub.io/api/news?id=82e5d3fda5a293dff2fa713c6c4149a19c62b368787d53938ff901385d815290",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna Inc. (NASDAQ:MRNA) is one of the 10 Stocks With Standout Gains. Moderna extended its winning streak to a fourth consecutive day on Tuesday, surging 6.27 percent to close at $55.40 apiece, as investors digested the looming launch of three new vaccines over the next two years. In a statement on the same day, Moderna […]",
                "category": "company",
                "datetime": 1781660899,
                "headline": "Moderna (MRNA) Climbs 6% as Firm Eyes Launch of 3 Vaccines"
              },
              {
                "id": 140649670,
                "url": "https://finnhub.io/api/news?id=642fce331c8444abaf51fc3b4eef47b04e8d5a28535ba9c4d52caf55657d439c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 9.1% in the afternoon session after investors positioned ahead of a pivotal FDA advisory committee review for its mRNA seasonal flu vaccine.",
                "category": "company",
                "datetime": 1781653024,
                "headline": "Why Is Moderna (MRNA) Stock Soaring Today"
              },
              {
                "id": 140649671,
                "url": "https://finnhub.io/api/news?id=5824dd272d5a19637eee74c2f36109bb5f54f94017b14220d4dd29c9168c35cb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "The U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on June 18 to assess the benefit-risk profile of mFlusiva.",
                "category": "company",
                "datetime": 1781646899,
                "headline": "MRNA Stock Surges As FDA Releases Positive Briefing Documents Ahead Of Key Vaccine Meeting"
              },
              {
                "id": 140648780,
                "url": "https://finnhub.io/api/news?id=ecbdda81f2dc40879a7e77e5e12a285e2e89864b6df0834862c2ded4e69fb7c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Retail investors reassess growth favorites as Robinhood’s job cuts ripple through a market tilting toward industrial and financial stocks, today, June 16, 2026.",
                "category": "company",
                "datetime": 1781646274,
                "headline": "Stock Market Today, June 16: Nvidia, Broadcom, and Micron Technology Lead Drop in Nasdaq"
              },
              {
                "id": 140653157,
                "url": "https://finnhub.io/api/news?id=0e77b7e674da8968d3d80a7e563fafdfb64ea73f6c9719a7c39a37b8f824e767",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/16/Finger-To-The-Graph-On-The-Monitor--Team.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Major U.S. indexes closed mixed on Tuesday, with the Dow Jones Industrial Average gaining 0.6% to 51,999.67.",
                "category": "company",
                "datetime": 1781645519,
                "headline": "Netflix, SoFi Technologies, Snap, Moderna And Our Bond AI: Why These 5 Stocks Are On Investors' Radars Today"
              },
              {
                "id": 140648972,
                "url": "https://finnhub.io/api/news?id=db681961ae3428d0e3738e88d9de85bcfc74ce58beba77b029c1b1ea2f549df5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "US equity indexes were mixed on Tuesday after the Dow Jones Industrial Average hit a new all-time in",
                "category": "company",
                "datetime": 1781641003,
                "headline": "US Equity Markets End Mixed as Dow Hits Record High Amid Lower Crude Oil Prices, Tech Stock Sell-Off"
              },
              {
                "id": 140647785,
                "url": "https://finnhub.io/api/news?id=dd33f6b1d852e88ea246f52bbf583b74983a55f7a3cfa64a7896227bc17d03ac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna (NASDAQ:MRNA) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday afternoon session. That extends a remarkable 2026 run for the mRNA pioneer. The move pushes Moderna stock to +94% year to date (YTD), easily the best performance in the major vaccine cohort. By comparison, Pfizer (NYSE:PFE) stock is ... Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?",
                "category": "company",
                "datetime": 1781637675,
                "headline": "Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?"
              },
              {
                "id": 140644517,
                "url": "https://finnhub.io/api/news?id=cb598e912c7728ef477b1c956648b4e5023be62b7bc2a8c8e1b6c9a6c7e1b65d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Highflying technology and artificial intelligence stocks are climbing early Tuesday but the rally isn't nearly as broad-based as the previous session.",
                "category": "company",
                "datetime": 1781634780,
                "headline": "SpaceX, Western Digital, Robinhood, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140647076,
                "url": "https://finnhub.io/api/news?id=3288a623d9efea4bf41605d8fd934c9690a14db9d0ed30b9d94ef570970f46a3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Moderna stock surged Tuesday after documents posted ahead of a key meeting suggested the FDA would likely approve its flu shot.",
                "category": "company",
                "datetime": 1781628471,
                "headline": "Moderna Surges On This Surprising FDA View For Its mRNA-Based Flu Shot"
              },
              {
                "id": 140655970,
                "url": "https://finnhub.io/api/news?id=4036054940c6a80051deb21b77422a7f3ddd2066647396f11ac61037cb97971a",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "https://www.fda.gov/media/193131/download",
                "category": "company",
                "datetime": 1781616266,
                "headline": "FDA Says Moderna's MRNA-1010 Influenza Vaccine Data May Support Use In Adults ≥50 Years Old"
              },
              {
                "id": 140646541,
                "url": "https://finnhub.io/api/news?id=fd9bf95f03369c61e21966eb8986cb2be0b50489c2b31d29737948d7fb3af05e",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/16/Portland--Or--Usa---Mar-12--2020-Dow-Jon_0.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Financials and utilities led Wall Street higher Tuesday as oil slid toward $77 and investors brace for Warsh&#39;s first Fed decision.",
                "category": "company",
                "datetime": 1781615575,
                "headline": "Dow Jones Hit Record Highs As Oil Drops To $77: Stock Market Today"
              },
              {
                "id": 140655972,
                "url": "https://finnhub.io/api/news?id=5d23e55a6dffa7394c50b9cb27ba7eb489176ceec23edd6cbc45f7ae42f927f3",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/16/Moderna.jpeg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Moderna expands leadership roles and commercial operations as it prepares for multiple vaccine launches and key clinical milestones.",
                "category": "company",
                "datetime": 1781614562,
                "headline": "Moderna Strengthens Commercial Strategy As Pipeline Advances"
              },
              {
                "id": 140644641,
                "url": "https://finnhub.io/api/news?id=9a045bcdf19b8797717015b013529f63698d0db490103f9095ca0815d1bdde9c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "MRNA",
                "summary": "Dr. Stephen Hoge, President of Moderna, to Assume an Expanded Role With Operational Oversight of the Company's Infectious Disease, Intismeran and Rare Disease Franchises Ester Banque to Join Moderna as Chief Commercial Officer CAMBRIDGE, MA / ACCESS ...",
                "category": "company",
                "datetime": 1781609400,
                "headline": "Moderna Announces Organizational Changes to Prepare for Multiple Product Launches in 2027 and 2028"
              },
              {
                "id": 140645405,
                "url": "https://finnhub.io/api/news?id=979d3b55417d69137753ef052c8d5ce4696dfc7a5ab7907269e3c9224ed8f793",
                "image": "",
                "source": "Benzinga",
                "related": "MRNA",
                "summary": "Moderna, Inc. (NASDAQ:MRNA) today announced changes to its operating model to support its short- and long-term business goals.As Moderna executes its long-range plan to become a diversified, multi-modality biotechnology",
                "category": "company",
                "datetime": 1781595252,
                "headline": "Moderna Intends To Roll Out Three New Products In 2027, 2028; Oversee Three Commercial Franchises"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 171,
            "discarded_article_count": 138
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 16.8,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.5,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日3日)；站上MA50；升放量(近10日2日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 8706970,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 8728390,
              "avg_vol_20": 10244015,
              "avg_vol_30": 8706970,
              "range_pct_10": 0.3176563737133807,
              "range_pct_20": 0.5374505146476642,
              "range_pct_30": 0.6603325415676959,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.0024600980593708,
              "dist_to_20d_high": 0.26226635514018687,
              "down_shrink_days": 3,
              "breakout_level_20d": 85.6,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4810551558752995
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 0.9,
            "details": {
              "atrPct": 8.925574030087095,
              "turnoverUsdM": 352.3638648,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.3
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.MRNA",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 51.877,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 17.9,
            "take_profit_price": 71.7175,
            "target_multiplier": 1.6,
            "technical_strength": 1.43,
            "take_profit_percent": 13.6
          },
          "positionPoints": 0.9,
          "stopLossPoints": 0.6,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 15,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 5.6365,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 2,
      "atr_pct": 8.93
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -48.76
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0382
    },
    "kdj": {
      "d": 31.87,
      "j": -16.15,
      "k": 15.86,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 65.78
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 38153908,
      "recentSlope": -759669.2,
      "previousSlope": 6173110
    },
    "rsi": 53.49,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 82.9642,
      "position": "SAR喺價上",
      "distancePct": 31.38,
      "previousTrend": "下降"
    },
    "ma50": 56.7865,
    "macd": {
      "macd": 3.561092127827905,
      "trend": "中性偏多",
      "signal": 5.08544058867285,
      "histogram": -1.5243484608449451
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 68.758,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.57,
      "score": 2,
      "avgVolume": 9870480,
      "currentVolume": 5579792
    },
    "derived": {
      "ma20": 68.5808,
      "ma50": 56.7865,
      "prevClose": 68.28,
      "avgVolume10": 8358839,
      "avgVolume20": 9870480,
      "changePercent": -7.51,
      "avgVolumeForScore": 9870480
    },
    "ma_cross": {
      "ma20": 68.5808,
      "ma50": 56.7865,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 68.1933,
      "prevMa50": 56.4695,
      "spreadPct": 20.77,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 54.9838,
      "upper": 82.1777,
      "position": "中間"
    },
    "rsi_short": 21.54,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.57
    }
  }
}

{
  "close": 63.15,
  "volume": 5579792,
  "changePercent": -7.51
}